Nov 11, 2016 12:00 pm UTC| Business
- ATLAS discovers neoantigens, through functional T cell responses, which were not identified by predictive algorithms - - Majority of antigens predicted by algorithms not biologically relevant in ATLAS assays - - Data...
Akari Therapeutics to Attend Upcoming Investor Conferences In November
Nov 11, 2016 12:00 pm UTC| Business
NEW YORK and LONDON, Nov. 11, 2016 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will attend and host...
Nov 11, 2016 12:00 pm UTC| Business
-- Biomarker Data Also Presented Indicating Evidence of Immune Activation-- --Data Presented at SITC’s 31st Annual Meeting--BURLINGAME, Calif., Nov. 11, 2016 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a...
Nov 11, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2016 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
Natus to Present at 28th Annual Piper Jaffray Healthcare Conference
Nov 11, 2016 12:00 pm UTC| Business
PLEASANTON, Calif., Nov. 11, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jonathan Kennedy, Executive Vice President and Chief Financial Officer, will present at the 28th Annual Piper Jaffray...
ChromaDex Announces the Results of Pre-IND meeting for Nicotinamide Riboside for Cockayne Syndrome
Nov 11, 2016 11:30 am UTC| Business
IRVINE, Calif., Nov. 11, 2016 -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions to dietary supplement, food and beverage,...
T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 11, 2016 11:30 am UTC| Business
LEXINGTON, Mass., Nov. 11, 2016 -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced thatJohn McDonough, president and chief executive officer, andShawn Lynch, chief financial officer, are scheduled to attend and...